SOURCE: Insiderslab Inc.

Insiderslab Inc.

May 19, 2011 09:15 ET

Daily Insider Trade Reports for Microsoft, Boston Scientific, Eli Lilly, Macy's, & Clearwire

VANCOUVER, BC--(Marketwire - May 19, 2011) - Due to recent insider trades properly filed with the SEC, Insiderslab.com today releases special stock alerts and investment research reports for following companies: Microsoft (MSFT), Boston Scientific (BSX), Eli Lilly (LLY), Macy's (M), & Clearwire (CLWR).

If investors are using insider trading data to prospect for new investments, usually they should not go any deeper than straightforward insider open-market purchases and sales. Insiderslab.com generates updated Insider Trading Charts and Statistics, clearly demarcate open-market from non-open-market insider trades, helping investors easily screen out the noise in thousands of insider trading data reported by SEC every day.

(Read full report by clicking the links, you may need to copy and paste the full link to your browser.)

Microsoft Corporation (MSFT): Open-market Sale made by company Directors on May 16th, at stock price (US$24.76). Disclose date: May 18th. Read Full Report: http://www.insiderslab.com/MW/051911B/MSFT/Microsoft (MSFT)

Boston Scientific Corporation (BSX): Open-market Purchase made by company Directors on May 17th, at stock price (US$6.72). Disclose date: May 18th. Read Full Report: http://www.insiderslab.com/MW/051911B/BSX/Boston-Scientific (BSX)

Eli Lilly & Co. (LLY): Open-market Sale made by company C-Level Officers on May 17th, at stock price (US$39.12). Disclose date: May 18th. Read Full Report: http://www.insiderslab.com/MW/051911B/LLY/Eli-Lilly (LLY)

Macy's, Inc. (M): Market Option Sale made by company Directors on May 18th, at stock price (US$28.65). Disclose date: May 18th. Read Full Report: http://www.insiderslab.com/MW/051911B/M/Macys (M)

Clearwire Corporation (CLWR): Open-market Sale made by company 10% Owners on May 18th, at stock price (US$4.47). Disclose date: May 18th. Read Full Report: http://www.insiderslab.com/MW/051911B/CLWR/Clearwire (CLWR)

Insider Buy Ratio of drug sector increased to 25%, for more details refer to http://www.insiderslab.com/media/news/460/.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research. Nothing contained in any materials should be construed as a recommendation to buy or sell any security. All calculated numbers are statistics based on the best available information and represent our best efforts toward accuracy. You can visit http://www.insiderslab.com and http://www.insiders.hk for a more complete account of product information and disclosures.

Important Disclaimer:
Please visit http://www.insiderslab.com/disclaimers/disclaimers.php for details.

Insider Filing Source Reference:
U.S. Securities Exchange and Commission

Contact Information